FDA Warning Letter — SCA Pharmaceuticals, Inc.

Case 724202 — FEI 3010683157

The FDA took a Warning Letter action against SCA Pharmaceuticals, Inc. on Sep 14, 2026 (Little Rock, AR). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
SCA Pharmaceuticals, Inc.
Date
Sep 14, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Little Rock, AR (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.